Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Leukemia|October 1, 1995
Alternative splicing of T cell receptor (TCR) alpha chain transcripts containing V alpha 1 or V alpha 14 elementsC Mahotka, T E Hansen-Hagge, C R BartramCancer Research|January 8, 2000
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic propertiesC Mahotka, M Wenzel, E Springer, et al.Leukemia|July 18, 2015
Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolinS Bhatia, S Reister, C Mahotka, et al.Anticancer Research|February 19, 2002
Topotecan (Hycamtin) responsiveness in human renal carcinoma cell lines of the clear cell and papillary typesU Ramp, C Mahotka, T Kalinski, et al.Cell Death and Differentiation|January 4, 2001
Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecanM Déjosez, U Ramp, C Mahotka, et al.Histology and Histopathology|July 10, 2007
Expression of heat shock protein 70 in renal cell carcinoma and its relation to tumor progression and prognosisU Ramp, C Mahotka, S Heikaus, et al.British Journal of Cancer|May 29, 2003
Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavageU Ramp, E Caliskan, C Mahotka, et al.Cell Death and Differentiation|December 13, 2002
Differential subcellular localization of functionally divergent survivin splice variantsC Mahotka, J Liebmann, M Wenzel, et al.British Journal of Cancer|March 20, 2003
TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potentialA Krieg, T Krieg, M Wenzel, et al.British Journal of Pharmacology|October 4, 2000
Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stabilityC V Suschek, E Bonmann, H Kleinert, et al.Pageof 2